Marian Gindy;Andrew Bett;Danilo R. Casimiro;Jan H. Ter Meulen
发明人:
Marian Gindy,Danilo R. Casimiro,Andrew Bett,Jan H. Ter Meulen
申请号：
US15120954
公开号：
US20160361411A1
申请日:
2015.02.23
申请国别(地区):
US
年份:
2016
代理人:
摘要：
The instant invention provides for novel lipid nanoparticle (LNP) formulations, containing cationic lipids, for use as vaccine adjuvants and/or as antigen delivery systems. It is an object of the instant invention to provide LNP formulations that demonstrate enhancements in humoral and cellular immunogenicity of vaccine antigens, particularly subunit vaccine antigens, when utilized alone or in combination with immunostimulatory agents (e.g. small molecule or oligonucleotide TLR agonists). The instant invention further identifies physical and chemical properties of the LNP formulations that can be manipulated to enhance antigen efficiency and adjuvant tolerability in vivo.
